ActiGraph CentrePoint Insight Watch— 510(k) K181077
Substantially EquivalentActigraph
FDA 510(k) clearance K181077 for ActiGraph CentrePoint Insight Watch, Substantially Equivalent on 2018-05-24. Applicant: Actigraph.
Clearance details
- Applicant
- Actigraph
- Product code
- Code LEL
- Advisory panel
- Neurology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Special
- Location
- Pensacola, FL, US
Data sourced from openFDA. This site is unofficial and independent of the FDA.